Literature DB >> 3253101

Effects of flunarizine on postischemic blood flow, energy metabolism and neuronal damage in the rat brain.

T Beck1, J Nuglisch, D Sauer, G W Bielenberg, H D Mennel, C Rossberg, J Krieglstein.   

Abstract

The effects of flunarizine on local cerebral blood flow, cortical energy metabolism and neuronal necrosis were evaluated in a rat model of forebrain ischemia. The application of flunarizine (2 X 40 mg/kg p.o.) at 24 and 4 h before ischemia accelerated the restoration of cortical high-energy phosphates during early post-ischemic recirculation and also increased the flow in cortical but not in hippocampal areas. Neuronal necrosis was reduced in the hippocampal CA 1 sector but unchanged in the cortex. It is concluded that flunarizine reduces ischemic damage mainly via a direct effect on brain tissue.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3253101     DOI: 10.1016/0014-2999(88)90078-7

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

Review 1.  Calcium, energy metabolism and the development of selective neuronal loss following short-term cerebral ischemia.

Authors:  N R Sims
Journal:  Metab Brain Dis       Date:  1995-09       Impact factor: 3.584

2.  On the effect of calcium antagonists on cerebral blood flow in rats. A comparison of nimodipine and flunarizine.

Authors:  M Zumkeller; H E Heissler; H Dietz
Journal:  Neurosurg Rev       Date:  1997       Impact factor: 3.042

3.  Nicergoline inhibits T-type Ca2+ channels in rat isolated hippocampal CA1 pyramidal neurones.

Authors:  K Takahashi; N Akaike
Journal:  Br J Pharmacol       Date:  1990-08       Impact factor: 8.739

4.  Effects of emopamil on postischemic blood flow and neuronal damage in rat brain.

Authors:  G W Bielenberg; D Sauer; J Nuglisch; T Beck; C Rossberg; H D Mennel; J Krieglstein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989 Jan-Feb       Impact factor: 3.000

5.  Leucocyte depletion does not affect post-ischaemic nerve cell damage in the rat.

Authors:  L Schürer; B Grögaard; B Gerdin; O Kempski; K E Arfors
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

Review 6.  Flunarizine. A reappraisal of its pharmacological properties and therapeutic use in neurological disorders.

Authors:  P A Todd; P Benfield
Journal:  Drugs       Date:  1989-10       Impact factor: 9.546

Review 7.  New anticonvulsant drugs. Focus on flunarizine, fosphenytoin, midazolam and stiripentol.

Authors:  M Bebin; T P Bleck
Journal:  Drugs       Date:  1994-08       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.